Filing Flows › VitaNova Life Sciences (VNOV) › Q1 FY26
VitaNova Life Sciences (VNOV) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Sep 12, 2025
VitaNova Life Sciences (VNOV) reported revenue of $104K for the first quarter fiscal 2026 (Q1 FY26), -4% from a year earlier and -95% from the quarter before. Operating margin was -31.2%, net loss $46K (44.6% of revenue).
VitaNova Life Sciences, Q1 FY26: revenue $104K (-4% year over year), operating margin -31.2%, net loss $46K, operating cash flow $264K. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $104K | -95% | -4% |
| Operating profit | −$32K | -103% | — |
| Net earnings | −$46K | -106% | — |
| Operating cash flow | $264K | -45% | — |
What changed
Revenue was $104K in Q1 FY26, down 4% year over year and down 95% from the previous quarter. Sale of Healthcare Products was the largest line at 96% of revenue. Sale of Healthcare Products lost $9K year over year (down 8%), 192% of the total change.
Gross margin was 66.2%, down 1.3 points from a year earlier. Operating costs exceeded revenue by $32K, an operating margin of -31.2%. Operating expenses fell 15% while revenue fell 4%. The fastest-growing cost line was General & admin (+15%). The quarter ended with a net loss of $46K, after a profit of $800K the previous quarter.
Operating cash flow was $264K. Working capital and other items added $310K.
Questions
What was VitaNova Life Sciences' revenue in the first quarter fiscal 2026?
VitaNova Life Sciences (VNOV) reported revenue of $104K for the first quarter fiscal 2026 (Q1 FY26), -4% from a year earlier and -95% from the quarter before.
Was VitaNova Life Sciences profitable in the first quarter fiscal 2026?
Operating loss was $32K (-31.2% of revenue) and net loss $46K.